Evidence map›Paper›PMID 37046730›Full record

ArticleCancers2023

Increased

Su Zhaoran, Christina Susanne Linnebacher, Michael Linnebacher

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. A Prognostic Riskscore Model Related toInternational journal of genomics · 2025
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Su ZhaoranDepartments of Gastrointestinal Surgery, People's Hospital of Tongling City, Tongling 244000, China.
Christina Susanne LinnebacherPatient Models for Precision Medicine, Clinic of General Surgery, University Medical Center Rostock, 18057 Rostock, Germany.
Michael LinnebacherMolecular Oncology and Immunotherapy, Clinic of General Surgery, University Medical Center Rostock, 18057 Rostock, Germany.ORCID 0000-0001-8054-1402
University of Rostock · DEThe People's Hospital Tongling · CN

Funding

Superior Department Construction Fund of Anhui Province 2022
6 · The paper itself

Abstract

backgroundPrevious studies have described that the MATERIALS AND

methods

results

conclusionsWe observed the significantly upregulated expression of

Indexed as

biomarkerimmune infiltrationprognosisSEC23Astomach adenocarcinoma

Identifiers

PMID37046730
PMCPMC10093042
OpenAlexW4362519969

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.